Preferred Label : Phenylketonuria;
Symbol : PKU;
CISMeF acronym : PKU;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Phenylalanine hydroxylase deficiency; Pah deficiency; Oligophrenia phenylpyruvica; Folling disease;
Included titles and symbols : Hyperphenylalaninemia, non-pku mild; Hpa, non-pku mild; Phenylketonuria, maternal;
Description : Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism resulting
from a deficiency of phenylalanine hydroxylase (PAH; 612349), an enzyme that catalyzes
the hydroxylation of phenylalanine to tyrosine, the rate-limiting step in phenylalanine
catabolism. If undiagnosed and untreated, phenylketonuria can result in impaired postnatal
cognitive development resulting from a neurotoxic effect of hyperphenylalaninemia
(Zurfluh et al., 2008). See Scriver (2007) and Blau et al. (2010) for detailed reviews
of PKU.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the phenylalanine hydroxylase gene (PAH, 261600.0001);
Laboratory abnormalities : Increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid
and phenylacetylglutamine;
Prefixed ID : #261600;
Origin ID : 261600;
UMLS CUI : C0751434;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT